Literature DB >> 20447672

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Shuliu Zhang1, Evgeniy I Bovshik, Rodrigo Maillard, Gregory D Gromowski, David E Volk, Catherine H Schein, Claire Y-H Huang, David G Gorenstein, James C Lee, Alan D T Barrett, David W C Beasley.   

Abstract

Site-directed mutagenesis of residues in the BC loop (residues 329-333) of the envelope (E) protein domain III in a West Nile virus (WNV) infectious clone and in plasmids encoding recombinant WNV and dengue type 2 virus domain III proteins demonstrated a critical role for residues in this loop in the function and antigenicity of the E protein. This included a strict requirement for the tyrosine at residue 329 of WNV for virus viability and E domain III folding. The absence of an equivalent residue in this region of yellow fever group viruses and most tick-borne flavivirus suggests there is an evolutionary divergence in the molecular mechanisms of domain III folding employed by different flaviviruses. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447672      PMCID: PMC2897250          DOI: 10.1016/j.virol.2010.03.038

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

Authors:  J J H Chu; R Rajamanonmani; J Li; R Bhuvanakantham; J Lescar; M-L Ng
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

3.  Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.

Authors:  Li Li; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2005-04-25       Impact factor: 3.616

4.  A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

Authors:  Shuliu Zhang; Li Li; Sara E Woodson; Claire Y-H Huang; Richard M Kinney; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2006-06-27       Impact factor: 3.616

5.  Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin.

Authors:  Jason Wei-Ming Lee; Justin Jang-Hann Chu; Mah-Lee Ng
Journal:  J Biol Chem       Date:  2005-11-07       Impact factor: 5.157

6.  Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.

Authors:  David W C Beasley; Melissa C Whiteman; Shuliu Zhang; Claire Y-H Huang; Bradley S Schneider; Darci R Smith; Gregory D Gromowski; Stephen Higgs; Richard M Kinney; Alan D T Barrett
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Crystal structure of the West Nile virus envelope glycoprotein.

Authors:  Grant E Nybakken; Christopher A Nelson; Beverly R Chen; Michael S Diamond; Daved H Fremont
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

8.  Avian virulence and thermostable replication of the North American strain of West Nile virus.

Authors:  Richard M Kinney; Claire Y-H Huang; Melissa C Whiteman; Richard A Bowen; Stanley A Langevin; Barry R Miller; Aaron C Brault
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

9.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Authors:  Theodore Oliphant; Michael Engle; Grant E Nybakken; Chris Doane; Syd Johnson; Ling Huang; Sergey Gorlatov; Erin Mehlhop; Anantha Marri; Kyung Min Chung; Gregory D Ebel; Laura D Kramer; Daved H Fremont; Michael S Diamond
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

10.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

View more
  17 in total

1.  Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody.

Authors:  Bimmi Shrestha; S Kyle Austin; Kimberly A Dowd; Abhishek N Prasad; Soonjeon Youn; Theodore C Pierson; Daved H Fremont; Gregory D Ebel; Michael S Diamond
Journal:  Virology       Date:  2012-03-09       Impact factor: 3.616

2.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

Authors:  Jessica A Plante; Maricela Torres; Claire Y-H Huang; David W C Beasley
Journal:  Virology       Date:  2016-06-07       Impact factor: 3.616

4.  A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus.

Authors:  Tsai-Yu Lin; Kimberly A Dowd; Carolyn J Manhart; Steevenson Nelson; Stephen S Whitehead; Theodore C Pierson
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

5.  Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.

Authors:  Haibin Liu; Yi Liu; Shaobo Wang; Yanjun Zhang; Xiangyang Zu; Zheng Zhou; Bo Zhang; Gengfu Xiao
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

6.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970

7.  The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.

Authors:  Phong D Lee; Swati Mukherjee; Melissa A Edeling; Kimberly A Dowd; S Kyle Austin; Carolyn J Manhart; Michael S Diamond; Daved H Fremont; Theodore C Pierson
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

8.  Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.

Authors:  David M Bowen; Jessica A Lewis; Wenzhe Lu; Catherine H Schein
Journal:  Vaccine       Date:  2012-07-31       Impact factor: 3.641

9.  Comparative genomic and phylogenetic analysis of the first Usutu virus isolate from a human patient presenting with neurological symptoms.

Authors:  Paolo Gaibani; Francesca Cavrini; Ernest A Gould; Giada Rossini; Anna Pierro; Maria Paola Landini; Vittorio Sambri
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 10.  The key amino acids of E protein involved in early flavivirus infection: viral entry.

Authors:  Tao Hu; Zhen Wu; Shaoxiong Wu; Shun Chen; Anchun Cheng
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.